Jacobs Levy Equity Management
INGN icon

Jacobs Levy Equity Management’s Inogen INGN Stock Holding History

Jacobs Levy Equity Management’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Buy
388,788
+91,819
+31% +$608K 0.01% 546
2026
Q1 		$1.84M Buy
296,969
+11,977
+4% +$73.9K 0.01% 601
2025
Q4 		$1.92M Sell
284,992
-10,690
-4% -$80.2K 0.01% 585
2025
Q3 		$2.42M Buy
295,682
+5,271
+2% +$39.4K 0.01% 555
2025
Q2 		$2.04M Sell
290,411
-4,306
-1% -$29K 0.01% 610
2025
Q1 		$2.1M Sell
294,717
-8,805
-3% -$83.1K 0.01% 648
2024
Q4 		$2.78M Buy
303,522
+12,654
+4% +$118K 0.01% 534
2024
Q3 		$2.82M Sell
290,868
-19,488
-6% -$204K 0.01% 536
2024
Q2 		$2.52M Sell
310,356
-61,982
-17% -$480K 0.01% 564
2024
Q1 		$3M Sell
372,338
-91,287
-20% -$646K 0.01% 524
2023
Q4 		$2.55M Buy
463,625
+64,302
+16% +$340K 0.01% 565
2023
Q3 		$2.08M Buy
399,323
+15,471
+4% +$110K 0.01% 553
2023
Q2 		$4.43M Buy
383,852
+25,655
+7% +$302K 0.03% 421
2023
Q1 		$4.47M Buy
358,197
+105,017
+41% +$2.01M 0.03% 424
2022
Q4 		$4.99M Sell
253,180
-1,505
-0.6% -$32.4K 0.03% 397
2022
Q3 		$6.18M Sell
254,685
-38,530
-13% -$1.06M 0.05% 346
2022
Q2 		$7.09M Buy
293,215
+13,017
+5% +$346K 0.05% 352
2022
Q1 		$9.08M Buy
280,198
+16,837
+6% +$529K 0.06% 315
2021
Q4 		$8.95M Buy
263,361
+89,326
+51% +$3.25M 0.06% 327
2021
Q3 		$7.5M Buy
174,035
+157,785
+971% +$9.7M 0.05% 358
2021
Q2 		$1.06M Buy
+16,250
New +$1.03M 0.01% 733
2019
Q1 		– Sell
-7,769
Closed -$965K – 989
2018
Q4 		$965K Sell
7,769
-6,792
-47% -$1.12M 0.02% 602
2018
Q3 		$3.56M Sell
14,561
-8,579
-37% -$1.98M 0.05% 386
2018
Q2 		$4.31M Sell
23,140
-570
-2% -$94.9K 0.07% 335
2018
Q1 		$2.91M Buy
23,710
+11,470
+94% +$1.4M 0.05% 391
2017
Q4 		$1.46M Buy
12,240
+2,200
+22% +$242K 0.03% 534
2017
Q3 		$955K Buy
10,040
+3,210
+47% +$309K 0.02% 591
2017
Q2 		$652K Buy
+6,830
New +$584K 0.01% 646

Other funds holding INGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jacobs Levy Equity Management's INGN Position: Q2 2026 in Review

Jacobs Levy Equity Management increased its Inogen (INGN) stake by 31% in Q2 2026, buying an estimated $608K and bringing the position to 388,788 shares worth $2.51M. The position accounts for 0.01% of the portfolio, ranked #546.

Jacobs Levy Equity Management first reported a position in INGN in Q2 2017 and has held it in 28 quarters since. The position peaked at $9.08M in Q1 2022. 129 funds tracked by Wall St. Rank hold INGN as of Q2 2026.

  • Jacobs Levy Equity Management held 388,788 shares of Inogen worth $2.51M as of Q2 2026.
  • Jacobs Levy Equity Management bought 91,819 Inogen shares in Q2 2026, an estimated $608K.
  • Inogen made up 0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #546 holding.
  • Jacobs Levy Equity Management first reported a position in Inogen in Q2 2017 and has held it in 28 quarters since.
  • Jacobs Levy Equity Management's Inogen position peaked at $9.08M in Q1 2022.
  • 129 funds tracked by Wall St. Rank held Inogen as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.